Achieve Life Sciences (ACHV) Reports In-Line Q4 EPS

Achieve Life Sciences (NASDAQ: ACHV) reported Q4 EPS of ($0.28), in-line with the analyst estimate of ($0.28).

For earnings history and earnings-related data on Achieve Life Sciences (ACHV) click here.

You May Also Be Interested In

• Jefferies upgrades Five Below to Buy, sees path to TJX-like re-rating
• MeiraGTx Holdings plc (MGTX) Tops Q2 EPS by 202c
• Truist Securities on Robinhood Markets (HOOD): 'Less Pain Than Predicted'